We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.84%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$5.33B
AUM Growth
+$2.47B
Cap. Flow
+$2.23B
Cap. Flow %
41.82%
Top 10 Hldgs %
41.66%
Holding
2,083
New
789
Increased
411
Reduced
285
Closed
597

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$359M
2
AEE icon
Ameren
AEE
+$68.9M
3
CMS icon
CMS Energy
CMS
+$36.8M
4
PYPL icon
PayPal
PYPL
+$35.6M
5
ETR icon
Entergy
ETR
+$31.5M

Top Sells

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$150M
2
LVS icon
Las Vegas Sands
LVS
+$62.2M
3
AEP icon
American Electric Power
AEP
+$36.3M
4
ORCL icon
Oracle
ORCL
+$30.2M
5
AAPL icon
Apple
AAPL
+$27.7M

Sector Composition

Rank Sector Weight
1 Utilities 13.47%
2 Technology 10.64%
3 Financials 6.44%
4 Consumer Discretionary 5.14%
5 Consumer Staples 4.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
1301
Philip Morris
PM
$297B
$221K ﹤0.01%
2,595
-11,756
-82% -$969K
BRSP
1302
BrightSpire Capital
BRSP
$619M
$220K ﹤0.01%
+16,700
New +$227K
KRG icon
1303
Kite Realty
KRG
$5.28B
$220K ﹤0.01%
+11,255
New +$203K
CYOU
1304
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$220K ﹤0.01%
+22,452
New +$216K
SAFT icon
1305
Safety Insurance
SAFT
$1.52B
$219K ﹤0.01%
+2,365
New +$231K
FBIO icon
1306
Fortress Biotech
FBIO
$98.1M
$218K ﹤0.01%
+5,647
New +$145K
NTCT icon
1307
NETSCOUT
NTCT
$2.76B
$218K ﹤0.01%
+9,066
New +$214K
FOXA icon
1308
Fox Class A
FOXA
$29B
$216K ﹤0.01%
5,839
-9,138
-61% -$313K
NYMX
1309
DELISTED
Nymox Pharmaceutical Corp
NYMX
$216K ﹤0.01%
+98,125
New +$194K
ACHC icon
1310
Acadia Healthcare
ACHC
$2.64B
$215K ﹤0.01%
6,479
-5,449
-46% -$171K
ALKS icon
1311
Alkermes
ALKS
$8.2B
$215K ﹤0.01%
10,536
-2,364
-18% -$47K
CDXS icon
1312
Codexis
CDXS
$185M
$215K ﹤0.01%
+13,421
New +$199K
EH
1313
EHang Holdings
EH
$398M
$215K ﹤0.01%
+20,000
New +$217K
NVMI
1314
Nova
NVMI
$11.5B
$215K ﹤0.01%
+5,690
New +$200K
TGS icon
1315
Transportadora de Gas del Sur
TGS
$4.3B
$215K ﹤0.01%
+29,933
New +$208K
CXW icon
1316
CoreCivic
CXW
$3.35B
$214K ﹤0.01%
+12,312
New +$195K
IDA icon
1317
Idacorp
IDA
$7.96B
$214K ﹤0.01%
+2,008
New +$215K
KMT icon
1318
Kennametal
KMT
$2.22B
$214K ﹤0.01%
5,800
-4,900
-46% -$164K
BUSE icon
1319
First Busey Corp
BUSE
$2.51B
$212K ﹤0.01%
+7,691
New +$203K
OCFT
1320
DELISTED
OneConnect Financial Technology
OCFT
$212K ﹤0.01%
+2,111
New +$209K
AMKR icon
1321
Amkor Technology
AMKR
$12B
$211K ﹤0.01%
16,233
-37,618
-70% -$449K
NAVI icon
1322
Navient
NAVI
$876M
$211K ﹤0.01%
15,396
-36,047
-70% -$485K
XPEL icon
1323
XPEL
XPEL
$1.39B
$211K ﹤0.01%
+14,406
New +$188K
EXLS icon
1324
EXL Service
EXLS
$5.72B
$209K ﹤0.01%
+15,010
New +$205K
DRNA
1325
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$209K ﹤0.01%
+9,484
New +$191K

Similar funds

Michael Gelband's Q4 2019 Portfolio in Review

As of Q4 2019, Michael Gelband held 2,083 positions worth $5.33B, up 86% from $2.86B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Michael Gelband deployed $2.23B of net new capital in Q4 2019, opening 789 new positions and adding to 411 existing holdings. Its largest new stake was PayPal: 341,834 shares worth $37M.

By sector, the portfolio is most concentrated in Utilities at 13% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Aramark, an estimated $150M trimmed.

  • Michael Gelband's largest Q4 2019 buy was PayPal: 341,834 shares worth $37M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $359M increase.
  • Michael Gelband's biggest Q4 2019 reduction was Aramark, cutting an estimated $150M.
  • Michael Gelband fully exited Las Vegas Sands in Q4 2019, selling an estimated $62.2M.
  • Michael Gelband's ten largest holdings make up 42% of its $5.33B portfolio in Q4 2019.
  • Michael Gelband opened 789 new positions and closed 597 in Q4 2019.
  • Michael Gelband's portfolio value rose 86% quarter-over-quarter to $5.33B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.